GlassScriptPhysician profile
Dustin J Reithmeier
NPI 1326321787
$3,934.56
in general payments reported to CMS, 2019-2025
19 companies · $1,842 in 2025
The $1,842 reported for 2025 was more than what 92% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $524 · 2022: $697 · 2023: $424 · 2024: $448 · 2025: $1,842.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,713.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,713.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aop Health US, LLC | $1,193.74 | 2025 | Rapiblyk |
| Abbott Laboratories | $1,105.92 | 2021-2025 | Aveir, Jot Dx, Ensite |
| Novartis Pharmaceuticals Corporation | $520.69 | 2021-2023 | |
| Edwards Lifesciences Corporation | $167.65 | 2024-2025 | Sapien 3 Ultra Resilia, Pascal |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $158.27 | 2022-2023 | Lifevest |
| Janssen Pharmaceuticals, INC | $144.59 | 2021-2024 | Xarelto |
| Irhythm Technologies, INC. | $130.49 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Pfizer INC. | $95.69 | 2022-2024 | |
| Sanofi-Aventis U.S. LLC | $87.87 | 2022-2024 | |
| Amgen INC. | $61.05 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $48.13 | 2021-2024 | Camzyos |
| Kestra Medical Technology Services, INC. | $47.98 | 2025 | Assure Wcd |
| Medtronic, INC. | $38.77 | 2022-2023 | Corevalve Evolut R |
| Impulse Dynamics (USA) INC. | $35.83 | 2022-2023 | Optimizer |
| Astrazeneca Pharmaceuticals LP | $27.48 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $19.86 | 2022 | |
| Atricure, INC. | $18.76 | 2021 | |
| Altathera Pharmaceuticals LLC | $16.85 | 2025 | Sotalol Hydrochloride |
| Kiniksa Pharmaceuticals, LTD. | $14.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dustin Reithmeier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.